218 related articles for article (PubMed ID: 29854823)
1. A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes.
Parilla JH; Willard JR; Barrow BM; Zraika S
J Diabetes Res; 2018; 2018():6106051. PubMed ID: 29854823
[TBL] [Abstract][Full Text] [Related]
2. Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes.
Wilson RD; Islam MS
Pharmacol Rep; 2012; 64(1):129-39. PubMed ID: 22580529
[TBL] [Abstract][Full Text] [Related]
3. Nongenetic mouse models of non-insulin-dependent diabetes mellitus.
Luo J; Quan J; Tsai J; Hobensack CK; Sullivan C; Hector R; Reaven GM
Metabolism; 1998 Jun; 47(6):663-8. PubMed ID: 9627363
[TBL] [Abstract][Full Text] [Related]
4. Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.
Nakamura T; Terajima T; Ogata T; Ueno K; Hashimoto N; Ono K; Yano S
Biol Pharm Bull; 2006 Jun; 29(6):1167-74. PubMed ID: 16755011
[TBL] [Abstract][Full Text] [Related]
5. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes.
Chao PC; Li Y; Chang CH; Shieh JP; Cheng JT; Cheng KC
Biomed Pharmacother; 2018 May; 101():155-161. PubMed ID: 29486333
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.
Fan M; Jiang H; Zhang Y; Ma Y; Li L; Wu J
Med Sci Monit; 2018 Apr; 24():2310-2316. PubMed ID: 29664069
[TBL] [Abstract][Full Text] [Related]
7. Effects of an olive oil-enriched diet on glucagon-like peptide 1 release and intestinal content, plasma insulin concentration, glucose tolerance and pancreatic insulin content in an animal model of type 2 diabetes.
Cancelas J; Prieto PG; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ
Horm Metab Res; 2006 Feb; 38(2):98-105. PubMed ID: 16523410
[TBL] [Abstract][Full Text] [Related]
8. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen treatment improves pancreatic β‑cell function and hepatic gluconeogenesis in STZ‑induced type‑2 diabetes mellitus model mice.
Zhang C; Zhang D; Wang H; Lin Q; Li M; Yuan J; Gao G; Dong J
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039874
[TBL] [Abstract][Full Text] [Related]
11. Novel canine models of obese prediabetes and mild type 2 diabetes.
Ionut V; Liu H; Mooradian V; Castro AV; Kabir M; Stefanovski D; Zheng D; Kirkman EL; Bergman RN
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E38-48. PubMed ID: 19843874
[TBL] [Abstract][Full Text] [Related]
12. Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic β-Cells.
Chen S; Han J; Liu Y
PLoS One; 2015; 10(9):e0137583. PubMed ID: 26335571
[TBL] [Abstract][Full Text] [Related]
13. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
Diabetes Obes Metab; 2016 Oct; 18(10):1013-24. PubMed ID: 27357054
[TBL] [Abstract][Full Text] [Related]
14. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
[TBL] [Abstract][Full Text] [Related]
15. A new mouse model of type 2 diabetes mellitus established through combination of high-fat diet, streptozotocin and glucocorticoid.
Liu S; Ma L; Ren X; Zhang W; Shi D; Huo Y; Ba Y; Bai Y; Cheng N
Life Sci; 2021 Dec; 286():120062. PubMed ID: 34673117
[TBL] [Abstract][Full Text] [Related]
16. Deteriorated high-fat diet-induced diabetes caused by pancreatic β-cell-specific overexpression of Reg3β gene in mice.
Xiong X; Li Q; Cui W; Gao ZH; Liu JL
Endocrine; 2016 Nov; 54(2):360-370. PubMed ID: 27259509
[TBL] [Abstract][Full Text] [Related]
17. Development of a nongenetic mouse model of type 2 diabetes.
Gilbert ER; Fu Z; Liu D
Exp Diabetes Res; 2011; 2011():416254. PubMed ID: 22164157
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of high fat diet-induced glucose intolerance by blockade of Smad4 in pancreatic beta-cells.
Li HY; Oh YS; Lee YJ; Lee EK; Jung HS; Jun HS
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):221-6. PubMed ID: 25502579
[TBL] [Abstract][Full Text] [Related]
19. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
20. Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice.
Brahma MK; Xiao P; Popa M; Negueruela J; Vandenbempt V; Demine S; Cardozo AK; Gurzov EN
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
